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July 31, 2012:432–3that these 2 tests are fundamentally different and provide different
information; we suggest that it is this difference that drives the
increased referral rate seen for CCTA.
CCTA is an anatomic test that provides information about the
presence, location, and severity of a stenosis but does not offer the
ability to determine whether the stenosis is responsible for isch-
emia. MPI is a functional test offering little in anatomic data but
providing clarity on the presence or absence of ischemia.
A patient with multiple risk factors presenting with angina (as
in 75% of the study population) who has a reported 65% left
anterior descending artery stenosis on CCTA would be deemed to
have a mild abnormality in the study. However, once these
anatomic data are obtained, we feel it would be difficult for the
clinician to ignore this finding, and hence further investigations
(likely angiography with a view to possible stenting) would be
requested. However, such a stenosis may not be flow limiting and
responsible for ischemia and may not be demonstrated on MPI. If
it is demonstrated that the ischemic burden may be low, further
tests may be unnecessary. We believe it is this that accounts for the
increased referral rates seen.
Before requesting a test, clinicians must decide whether they are
seeking anatomic or functional data.
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Reply
We thank Dr. McEvoy and colleagues for their comments on our
paper (1). The patients included in this report of the SPARC
(Study of Myocardial Perfusion and Coronary Anatomy Imaging
Roles in Coronary Artery Disease [CAD]) registry did not have a
prior history of CAD and were required to have intermediate to
high pretest likelihood of CAD. The SPARC exclusion criteria
mandated that patients be clinically stable. Thus, patients with
unstable angina (resting chest pain) within 48 h of testing were
excluded.
We agree with the comments that the use of patient self-
reported medication changes and the relatively short-term
follow-up likely overestimated the suboptimal use of medical
therapy, especially given the known fact that compliance withmedical therapy is reduced over time as demonstrated by Dr.
McEvoy and colleagues and others. We also agree that the 1-year
follow-up data from SPARC will add potentially important
information on this question in symptomatic patients.
We were also surprised about the relatively low referral rate to
catheterization, especially among those with high-grade CAD on
computed tomography angiography. It is important to note that
these relatively low referral rates to catheterization after stress
cardiac single-photon emission computed tomography were first
reported more than 15 years ago and confirmed by multiple
studies.
Our findings indicated that an additional facet of excess testing
includes the failure of referring physicians to act on the results of
testing in “appropriate” patients. Although patient selection, image
acquisition, image interpretation, and results communication have
been identified as the key components of imaging quality (1),
referring physicians’ action, implicated in this process via pretest
patient selection and posttest patient management, must also be
considered a necessary component of the definition of imaging
quality. We can no longer assume that communication of results
ensures optimal patient care. Finally, we agree with Dr. McEvoy
and colleagues that we were all taught that one should not order a
test without a clear plan as to how the results will impact
subsequent treatment. Perhaps this mantra can be revisited.
We thank Drs. Cookson and Sahebjalal for their comments and
agree that before ordering a test, physicians must decide what type
of information they are seeking. In the authors’ example, they
stated that it would be difficult for a referring physician to “ignore”
a 65% left anterior descending artery stenosis on coronary com-
puted tomography angiography and he would need to investigate
further. We agree that the physiological significance of this lesion
would need to be investigated, usually with a stress test. However,
the use of stress myocardial perfusion imaging post–computed
tomography angiography in the SPARC registry was actually
relatively low.
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